UnknownNot Applicable

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

China200 participantsStarted 2015-03

Plain-language summary

Patients undergoing haploidentical allo-HSCT will be prospectively enrolled exploring the NK cells phenotype and functional reconstitution.

Who can participate

Age range15 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * AML or MDS or CML or ALL undergoing haploidentical stem cells transplantation Exclusion Criteria: * NR or refractory AML/ALL before transplantation donors from mother or collateral related

What they're measuring

Immune Reconstitution differences between two group

Timeframe: 1 year

Trial details

NCT IDNCT02978274

SponsorPeking University People's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12

Contact for this trial

Xiangyu Zhao, M.D., PhD

+8610-88325949 xyz80421@126.com

View on ClinicalTrials.gov More Natural Killer Cell Mediated Immunity trials